Ocular Infection

Ocular Infection encompasses a broad spectrum of microbial conditions affecting the cornea, conjunctiva, sclera, intraocular structures, and surrounding tissues. As a critical topic at a global Ophthalmology Conference, this field examines the epidemiology, diagnosis, antimicrobial management, and prevention of sight-threatening infections. Rapid identification and treatment are essential to prevent irreversible eye infections that may lead to corneal scarring, endophthalmitis, or permanent vision loss.

Ocular infections may be bacterial, viral, fungal, or parasitic in origin. Conjunctivitis remains one of the most common infectious presentations, while microbial keratitis and endophthalmitis represent ophthalmic emergencies requiring urgent intervention. Risk factors include contact lens misuse, ocular trauma, postoperative contamination, immunosuppression, and poor hygiene practices. Emerging antimicrobial resistance patterns present additional challenges, necessitating vigilant microbiological surveillance and evidence-based prescribing.

Diagnostic evaluation involves slit-lamp examination, corneal scraping for culture and sensitivity testing, polymerase chain reaction assays, and imaging when intraocular involvement is suspected. Advances in molecular diagnostics enable rapid pathogen identification, allowing targeted therapy and improved outcomes. Early recognition of fungal or atypical organisms is particularly important in tropical and agricultural regions.

Management strategies depend on the causative agent and severity of infection. Topical broad-spectrum antibiotics are commonly initiated empirically for bacterial keratitis, while antiviral agents address herpetic infections. Intravitreal antibiotics are critical in managing postoperative endophthalmitis. Supportive therapies aim to reduce inflammation and preserve ocular structures during recovery.

Preventive strategies emphasize patient education, surgical asepsis, and appropriate contact lens hygiene. Vaccination programs and infection control protocols contribute to reducing systemic infections with ocular manifestations. Research continues to explore novel antimicrobial agents, drug delivery systems, and biofilm-targeting therapies to combat resistant pathogens.

Artificial intelligence–based diagnostic tools and teleophthalmology platforms are expanding early detection capabilities, particularly in underserved communities. Through interdisciplinary collaboration and innovation, advances in ocular infection management continue to improve visual prognosis and public health outcomes worldwide.